Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Okada

Showing results (211-220 of 254) with videos related to

Pageof 26
Sort By:
Journal of Bone and Mineral Metabolism|August 27, 2015
Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) studyYoshiya Tanaka, Hiroko Mori, Takatoshi Aoki, et al.
International Journal of Hematology|July 22, 2023
Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantationYosuke Okada, Hideki Nakasone, Kazuki Yoshimura, et al.
Journal of Diabetes Investigation|June 16, 2020
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trialAtsushi Tanaka, Michio Shimabukuro, Noritaka Machii, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 7, 2020
[Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study]Masahiro Teramoto, Takehiro Sone, Kohei Takada, et al.
The American Journal of Surgical Pathology|January 30, 2024
Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell TransplantationRyumei Kurashige, Masako Kurashige, Yosuke Okada, et al.
Transplantation and Cellular Therapy|May 16, 2022
Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood TransplantationYosuke Okada, Hideki Nakasone, Takaaki Konuma, et al.
Bone Marrow Transplantation|June 6, 2022
Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Shimpei Matsumi, Hideki Nakasone, et al.
Cardiovascular Diabetology|July 31, 2023
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)Atsushi Tanaka, Hirotaka Shibata, Takumi Imai, et al.
Leukemia & Lymphoma|April 7, 2022
Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Hideki Nakasone, Yuhei Nakamura, et al.
Haematologica|June 20, 2024
Decision analysis for transplant candidates with primary myelofibrosis in the ruxolitinib eraYosuke Okada, Hideki Nakasone, Shunto Kawamura, et al.
Pageof 26

Showing results (211-220 of 254) with videos related to

Sort By:
Pageof 26
Journal of Bone and Mineral Metabolism|August 27, 2015
Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) studyYoshiya Tanaka, Hiroko Mori, Takatoshi Aoki, et al.
International Journal of Hematology|July 22, 2023
Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantationYosuke Okada, Hideki Nakasone, Kazuki Yoshimura, et al.
Journal of Diabetes Investigation|June 16, 2020
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trialAtsushi Tanaka, Michio Shimabukuro, Noritaka Machii, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 7, 2020
[Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study]Masahiro Teramoto, Takehiro Sone, Kohei Takada, et al.
The American Journal of Surgical Pathology|January 30, 2024
Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell TransplantationRyumei Kurashige, Masako Kurashige, Yosuke Okada, et al.
Transplantation and Cellular Therapy|May 16, 2022
Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood TransplantationYosuke Okada, Hideki Nakasone, Takaaki Konuma, et al.
Bone Marrow Transplantation|June 6, 2022
Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Shimpei Matsumi, Hideki Nakasone, et al.
Cardiovascular Diabetology|July 31, 2023
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)Atsushi Tanaka, Hirotaka Shibata, Takumi Imai, et al.
Leukemia & Lymphoma|April 7, 2022
Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Hideki Nakasone, Yuhei Nakamura, et al.
Haematologica|June 20, 2024
Decision analysis for transplant candidates with primary myelofibrosis in the ruxolitinib eraYosuke Okada, Hideki Nakasone, Shunto Kawamura, et al.
Pageof 26